Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
Coherus BioSciences (Nasdaq: CHRS) has announced that its senior management will present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences (Nasdaq: CHRS) has announced that its senior management will present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit. This event, set for May 29, 2024, at 12:00 p.m. EDT, will provide insights ahead of the ASCO and EHA conferences. The presentation will be available via webcast through the Coherus website until June 26, 2024. This offers an opportunity for investors and stakeholders to gain valuable insights from Coherus' management team. For more information, investors can reach out to Jami Taylor, Head of Investor Relations at Coherus.
Positive
- Coherus will present at a significant oncology summit, which can enhance its visibility and credibility in the oncology sector.
- The event precedes major conferences, ASCO and EHA, potentially positioning Coherus as a thought leader in the industry.
- The webcast will be available for replay until June 26, 2024, providing extended accessibility for interested parties.
Negative
- There are no new financial or clinical data disclosed in the PR, which may leave investors wanting more concrete updates.
- The announcement does not mention any new partnerships, acquisitions, or product launches, which could have been potential catalysts for the stock.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was -4.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA on Wednesday, May 29, 2024 at 12:00 p.m. Eastern Daylight Time / 9:00 a.m. Pacific Daylight Time. The presentation will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations. This webcast will be available for replay until June 26, 2024.
Coherus Contact Information:
For Investors:
Jami Taylor
Head of Investor Relations
IR@coherus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.